Provided by Tiger Fintech (Singapore) Pte. Ltd.

MiMedx Group, Inc.

6.32
-0.5600-8.14%
Post-market: 6.320.00000.00%16:27 EDT
Volume:1.51M
Turnover:9.65M
Market Cap:931.35M
PE:22.35
High:6.68
Open:6.60
Low:6.18
Close:6.88
Loading ...

MiMedx sees FY25 revenue up at least high single-digits

TIPRANKS
·
27 Feb

MiMedx Group Q4 Adj $0.07, Inline, Sales $92.91M Beat $89.42M Estimate

Benzinga
·
27 Feb

BRIEF-MiMedx Q4 Sales USD 92.907 Million Vs. IBES Estimate USD 89.4 Million

Reuters
·
27 Feb

MiMedx Q4 Gross Profit USD 75.998 Million

THOMSON REUTERS
·
27 Feb

MiMedx Group Inc Outlook 2025 Net Sales Growth of at Least High Single-Digits as a Percentage

THOMSON REUTERS
·
27 Feb

MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results

GlobeNewswire
·
27 Feb

Do MiMedx Group's (NASDAQ:MDXG) Earnings Warrant Your Attention?

Simply Wall St.
·
26 Feb

Craig-Hallum Sticks to Their Buy Rating for MiMedx Group (MDXG)

TIPRANKS
·
24 Feb

Analysts’ Top Healthcare Picks: MiMedx Group (MDXG), Axsome Therapeutics (AXSM)

TIPRANKS
·
24 Feb

MediWound Launches Phase III Trial Evaluating EscharEx for Treating Venous Leg Ulcers

MT Newswires Live
·
12 Feb

Insiders At MiMedx Group Sold US$659k In Stock, Alluding To Potential Weakness

Simply Wall St.
·
07 Feb

While shareholders of MiMedx Group (NASDAQ:MDXG) are in the black over 3 years, those who bought a week ago aren't so fortunate

Simply Wall St.
·
05 Feb

MiMedx Group, Inc.'s (NASDAQ:MDXG) one-year returns climbed after last week's 6.2% gain, institutional investors must be happy

Simply Wall St.
·
22 Jan

MiMedx Group, Inc.'s (NASDAQ:MDXG) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Simply Wall St.
·
07 Jan

BRIEF-MiMedx Group Files Patent Infringement Lawsuit Against Surgenex

Reuters
·
17 Dec 2024

MiMedx files patent infringement lawsuit against Surgenex

TIPRANKS
·
17 Dec 2024

MiMedx Group: Files Patent Infringement Lawsuit Against Surgenex

THOMSON REUTERS
·
17 Dec 2024

MiMedx Group: Lawsuit Seeks Permanent Injunctive Relief and Monetary Damages

THOMSON REUTERS
·
17 Dec 2024

MIMEDX Files Patent Infringement Lawsuit Against Surgenex

GlobeNewswire
·
17 Dec 2024

Poseida Therapeutics, Inc. (PSTX) Hits Fresh High: Is There Still Room to Run?

Zacks
·
13 Dec 2024